Trends in Medication Usage in Juvenile Idiopathic Arthritis: Prescribing Trends or Trends in Prescribers?

REFERENCES

1. 1.↵
   1. Petty RE,
   2. Southwood TR,
   3. Manners P,
   4. Baum J,
   5. Glass DN,
   6. Goldenberg J,
   7. et al.

   International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390–2.

   OpenUrlFREE Full Text
2. 2.↵
   1. Mannion ML,
   2. Xie F-L,
   3. Curtis JR,
   4. Beukelman T

   . Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors. J Rheumatol 2014;41:2078–84.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Chung CP,
   2. Rohan P,
   3. Krishnaswami S,
   4. McPheeters ML

   . A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data. Vaccine 2013;31 Suppl 10:K41–61.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Widdifield J,
   2. Bernatsky S,
   3. Paterson JM,
   4. Tu K,
   5. Ng R,
   6. Thorne JC,
   7. et al.

   Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists. Arthritis Care Res 2013;65:1582–91.

   OpenUrl
5. 5.↵
   1. American Board of Pediatrics.

   Workforce data 2013–2014. 2014. [Internet. Accessed August 5, 2014.] Available from: www.abp.org/abpwebsite/stats/wrkfrc/workforcebook.pdf
6. 6.↵
   1. Roussy JP,
   2. Bessette L,
   3. Rahme E,
   4. Bernatsky S,
   5. Legare J,
   6. Lachaine J

   . Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada. Rheumatol Int 2013 Aug 20 (E-pub ahead of print).
7. 7.↵
   1. Lacaille D,
   2. Anis AH,
   3. Guh DP,
   4. Esdaile JM

   . Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum 2005;53:241–8.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Beukelman T,
   2. Patkar NM,
   3. Saag KG,
   4. Tolleson-Rinehart S,
   5. Cron RQ,
   6. DeWitt EM,
   7. et al.

   2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 2011;63:465–82.

   OpenUrlCrossRef
9. 9.↵
   1. Fitch K,
   2. Bernstein SJ,
   3. Aguilar MD,
   4. Burnand B,
   5. Lazaro P

   . The RAND/UCLA Appropriateness Method User’s Manual. Pittsburgh: RAND Corp; 2000.
10. 10.↵
    1. Ringold S,
    2. Weiss PF,
    3. Beukelman T,
    4. Dewitt EM,
    5. Ilowite NT,
    6. Kimura Y,
    7. et al.

    2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 2013;65:2499–512

    OpenUrlPubMed
11. 11.↵
    1. Saag KG,
    2. Teng GG,
    3. Patkar NM,
    4. Dewitt EM,
    5. Ilowite NT,
    6. Kimura Y,
    7. et al.

    American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762–84.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Singh JA,
    2. Furst DE,
    3. Bharat A,
    4. Curtis JR,
    5. Kavanaugh AF,
    6. Kremer JM,
    7. et al.

    2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625–39.

    OpenUrlCrossRef
13. 13.↵
    1. Kim SC,
    2. Yelin E,
    3. Tonner C,
    4. Solomon DH

    . Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983–2009. Arthritis Care Res 2013;65:1529–33.

    OpenUrlCrossRef
14. 14.↵
    1. Wallace CA,
    2. Giannini EH,
    3. Spalding SJ,
    4. Hashkes PJ,
    5. O’Neil KM,
    6. Zeft AS,
    7. et al.

    Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2012;64:2012–21.

    OpenUrlCrossRefPubMed